Postoperative External Beam Radiotherapy for Retroperitoneal Soft Tissue Sarcoma

다국어 초록 (Multilingual Abstract)

Purpose: To evaluate the clinical outcomes and prognostic factors in retroperitoneal soft tissue sarcomas treated by postoperative radiotherapy.
Materials and Methods: The records of 23 patients with retroperitoneal soft tissue sarcomas, who underwent postoperative radiotherapy between 1985 and 2003, were analyzed. The median follow-up period was 77 months (range, 8∼240 months). A total of 21 patients presented with primary disease, and two patients presented with recurrent disease. Liposarcomas and leiomyosarcomas represented 78% of the diagnosed tumor cases. Moreover, 17 cases were of high grade (grade 2 or 3). The median tumor size was 13 cm (range, 3∼50 cm). Complete excision was achieved in 65% of patients. The median radiation dose was 50.4 Gy (range, 45.0 to 59.4 Gy), with conventional fractionation.
Results: The 5-year overall, local recurrence-free, and distant metastasis-free survival rates were 68%, 58%, and 71%, respectively. Eleven patients experienced local recurrence, while 9 patients experienced distant metastasis. The most common site for distant metastasis was the liver. A univariate analysis revealed that adjacent organ invasion and age (＞60 years) as the significant risk factors contributing to the prediction of poor overall survival. Moreover, multivariate analyses indicated that adjacent organ invasion remained significantly associated with a higher risk of death. In addition, patient age (＞60 years) was the other identified risk factor for local recurrence by univariate and multivariate analyses. Except for one case of grade 3 diarrhea, no patient suffered grade 3 or higher complications.
Conclusion: Our results were comparable to previous reports in that adjacent organ invasion and patient age (＞60 years) were significant predictors of poor survival and tumor recurrence, respectively.

참고문헌 (Reference)

1 Cox JD, "Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)" 31 : 1341-1346, 1995

2 Oken MM, "Toxicity and response criteria of the Eastern Cooperative Oncology Group" 5 : 649-655, 1982

3 Costa J, "The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases" 53 : 530-541, 1984

4 Gilbeau L, "Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma" 65 : 137-143, 2002

5 Bobin JY, "Surgical management of retroperitoneal sarcomas associated with external and intraoperative electron beam radiotherapy" 29 : 676-681, 2003

6 Clark JA, "Role of radiation therapy in retroperitoneal sarcomas" discussion 1872-1864 10 : 1867-1872, 1996

7 Lewis JJ, "Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution" 355-365, 1998

8 Gronchi A, "Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution" 100 : 2448-2455, 2004

9 Ballo MT, "Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment" 67 : 158-163, 2007

10 Mendenhall WM, "Retroperitoneal soft tissue sarcoma" 104 : 669-675, 2005

11 Karakousis CP, "Resectability and survival in retroperitoneal sarcomas" 3 : 150-158, 1996

12 Yang JC, "Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity" 16 : 197-203, 1998

13 Tepper JE, "Radiation therapy of retroperitoneal soft tissue sarcomas" 10 : 825-830, 1984

14 Singer S, "Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma" 185-195, 1995

15 Stoeckle E, "Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group" 92 : 359-368, 2001

16 Heslin MJ, "Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management" 15 : 2832-2839, 1997

17 O'Sullivan B, "Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial" 2235-2241, 2002

18 Tzeng CW, "Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma" 107 : 371-379, 2006

19 Fiveash JB, "Preoperative IMRT with dose escalation to tumor subvolumes for retroperitoneal sarcomas: initial clinical results and potential for future dose escalation" 54 : 140-, 2002

20 Kim WD, "Postoperative radiotherapy in the treatment of soft tissue sarcomas" 13 : 69-78, 1995

21 Catton CN, "Outcome and prognosis in retroperitoneal soft tissue sarcoma" 29 : 1005-1010, 1994

22 Fein DA, "Management of retroperitoneal sarcomas: does dose escalation impact on locoregional control?" 31 : 129-134, 1995

23 Pawlik TM, "Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate-or high-grade retroperitoneal soft tissue sarcoma" 13 : 508-517, 2006

24 Pisters PW, "Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma" 14 : 859-868, 1996

25 Van Dalen T, "Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients" 27 : 564-568, 2001

26 Jones JJ, "Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma" 9 : 346-354, 2002

27 Van Dalen T, "Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma" 11 : 483-490, 2004

28 Greene F, "American Joint Committee on Cancer (AJCC) Cancer Staging Manual" Springer-Verlag 2002

29 Zlotecki RA, "Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma: the University of Florida experience" 28 : 310-316, 2005